We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

International Biotechnology Trust plc (IBT) Ordinary 25p Shares

Sell:682.00p Buy:688.00p 0 Change: 10.00p (1.48%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:682.00p
Buy:688.00p
Change: 10.00p (1.48%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:682.00p
Buy:688.00p
Change: 10.00p (1.48%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. The Company’s investments may also be made in related sectors, such as medical devices and healthcare services. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. SV Health Managers LLP is the Company's alternative investment fund manager (AIFM).

Important dates

Future events
Interim dividend payment date 24 January 2025 24/01/25
Past events
Interim ex-dividend date 19 December 2024 19/12/24
Final results 05 November 2024 05/11/24
Annual report 05 November 2024 05/11/24
Interim dividend payment date 23 August 2024 23/08/24
Interim ex-dividend date 25 July 2024 25/07/24
Interim results 08 May 2024 08/05/24
Interim dividend payment date 26 January 2024 26/01/24

General stock information

EPIC:
IBT
ISIN:
GB0004559349
Market cap:
£247.32 million
Shares in issue:
36.16 million
Sector:
Equity Investment Instruments
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE All Share,FTSE Small Cap

Contact details

Address:
6th Floor, 65 Gresham Street,
LONDON
EC2V 7NQ
United Kingdom
Telephone:
+44 (020) 74217070
Website:
https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.